Clinical Trial Update: Symptom-inhibited Fentanyl Induction [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating a symptom-inhibited fentanyl induction for opioid use disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder

Drugs mentioned

• FENTANYL (FENTANYL)

Snippet

Sponsor: Pouya Azar | Conditions: Opioid Use Disorder | Phase 4 | Status: COMPLETED